Genotyping Market Research Report-Global Forecast till 2027

Genotyping Market Trends, Growth and Insights by Technology (Sequencing, Capillary Electrophoresis, PCR, and Others), Product (Reagents and Kits and Others), Application (Diagnostics and Others), End-User (Hospitals, Diagnostic Centers), and Region-Forecast till 2027

ID: MRFR/LS/5172-HCR | February 2021 | Region: Global | 85 pages

Genotyping Market Scenario

The genotyping market accounted for USD 6120 million in 2015 and expected to register healthy growth during the forecast period (2018–2023) at a CAGR of 22.5%.

Genotyping services help to understand the genetic structure of any living organisms such as humans, animals, plants, and microorganisms. Human genotyping provides data related to the genetic history of an individual; microorganism genotyping provide aid in research and development of bacterial and viral diseases. The increasing research and development activities in the healthcare sector, rising prevalence of genetic diseases, technological advancement, and surge in demand for personalized medication are expected to drive the growth of the genotyping market. Moreover, decreasing prices of genotyping services due to intense competition is contributing to the growth of the market. According to the Centers for Disease Control and Prevention (CDC), Genetic disorders are constantly increasing, and in the US more than 120000 babies are born with congenital disabilities, which are caused by genetic changes.

The uncertainty related to reimbursement and lack of skilled people may hamper the growth of the market during the assessment period.

Genotyping Market Segmentation

The Genotyping Market has been segmented on the basis of technology, product, application, and end-user.

On the basis of technology, the market has been classified as sequencing, capillary electrophoresis, PCR, microarray, and mass spectrometry. The sequencing segment has been further divided into next-generation sequencing, pyrosequencing, and Sanger sequencing. The Capillary electrophoresis segment has been further divided into amplified fragment length polymorphism (AFLP),single-strand conformation polymorphism (SSCP), and restriction fragment length polymorphism (RFLP). The microarray segment has been classified as DNA microarrays, antibody microarrays, MMChips, and peptide microarrays.

The product segment has been divided into reagents and kits, instruments, and services.

The application segment has been classified into diagnostics, drug discovery and development, agriculture, academic research, and personalized medicine.

The genotyping market, by end-user, has been segmented into hospitals, diagnostic centers, academic institutes, and research and development centers.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European genotyping market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East & Africa has been segmented into the Middle East and Africa.

Regional Market Summary

Global Genotyping Market Share, by Region, 2017 (%)

Global Genotyping Market Share, by Region, 2017 (%)

Source: MRFR Analysis

The Americas are likely to dominate the global genotyping market owing to the well-established healthcare sector, increasing demand for personalized medicines, and a surge in research and development activities in the region. Moreover, increasing cases of genetic disorders is propelling the growth of the market. According to the report published by Alzheimer's Association in 2018, Prevalence of Alzheimer's disease is continuously increasing, and in the US 5.7 million Americans are living with the disease also it costs around USD 277 billion to the nation.

The European market is expected to be the second-largest genotyping market. The market growth in this region can be attributed to the increase in healthcare expenditure, government initiatives for increasing research and development in the region and increasing expenditure on R&D by pharmaceutical companies. According to the European Federation of Pharmaceutical Industries and Associations in 2015, pharmaceutical companies in the European region invested more than USD 38664 million in research and development activities.

Asia-Pacific is expected to be the fastest-growing genotyping market during the forecast period due to the increasing disposable income, favorable government policies, and rising investments in healthcare and expansions by market players in the region. For instance, in April 2018, Agilent Technologies, Inc. has opened a global solution development center in Singapore to provide services related to pharma, biopharma, lipidomic, and food testing.

The market in the Middle East & Africa is expected to account for the smallest share of the global genotyping market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

Key Players

Some of the key players in the global genotyping market are QIAGEN, Affymetrix, Inc., Illumina, Inc, Thermo Fisher Scientific, Inc., General Electric Company, Agilent Technologies, Inc., Fluidigm Corporation, Sequenom, F. Hoffmann-La Roche Ltd, and Beckman Coulter, Inc.

The Market of Genotyping, by Technology

Technology

Sequencing

Next-Generation Sequencing

Pyrosequencing

Sanger Sequencing

Capillary Electrophoresis

Amplified Fragment Length Polymorphism (AFLP)

Single-Strand Conformation Polymorphism (SSCP)

Restriction Fragment Length Polymorphism (RFLP)

Microarray

DNA Microarrays

Antibody Microarrays

Mmchips

Peptide Microarrays

Mass Spectrometry

The Market of Genotyping, by Product

Reagents and Kits

Instruments

Sequencer

Amplifiers

Services

The Market of Genotyping, by Application

Diagnostics

Drug Discovery and Development

Academic Research

Research and Development Centers

The Market of Genotyping, by End User

Hospitals

Diagnostic Centers

Academic Institutes

Research and Development Centers

The Market of Genotyping, by Region

Americas

North America

Canada

South America

Europe

Western Europe

Germany

France

Italy

Spain

Rest of Western Europe

Eastern Europe

Asia-Pacific

Japan

China

India

Australia

South Korea

Rest of Asia-Pacific

Middle East & Africa

Middle East

Africa

Intended Audience

Biotechnology companies

Bioinformatics service providers

Medical devices manufacturers

Bio supplier companies

Genotyping product distributors and suppliers

Healthcare providers

Research institutes and academic centers

Speak to Analyst Ask for Customization

Table of Contents

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Genotyping Market, by Technology

6.1 Introduction

6.2 Sequencing

6.2.1 Next-Generation Sequencing

Market Estimates & Forecast, by Region, 2020-2027